PND9 Comparative Efficacy and Safety of Ozanimod Versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Matching-Adjusted Indirect Comparison

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison

CNS Drugs ◽

10.1007/s40263-021-00805-0 ◽

2021 ◽

Author(s):

Stanley Cohan ◽

Jinender Kumar ◽

Stella Arndorfer ◽

Xuelian Zhu ◽

Marko Zivkovic ◽

...

Keyword(s):

Multiple Sclerosis ◽

Indirect Comparison ◽

Dimethyl Fumarate ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Relapsing Remitting ◽

Adjusted Indirect Comparison ◽

Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis

Value in Health ◽

10.1016/j.jval.2015.09.2902 ◽

2015 ◽

Vol 18 (7) ◽

pp. A750 ◽

Cited By ~ 3

Author(s):

RJ Fox ◽

G Cutter ◽

A Chan ◽

J Xiao ◽

M Okwuokenye ◽

...

Keyword(s):

Multiple Sclerosis ◽

Comparative Effectiveness ◽

Indirect Comparison ◽

Dimethyl Fumarate ◽

Delayed Release ◽

Relapsing Remitting ◽

Adjusted Indirect Comparison ◽

A randomized double-blind trial of comparative efficacy and safety of Avonex and CinnoVex for treatment of relapsing-remitting multiple sclerosis

Neurological Sciences ◽

10.1007/s10072-018-3550-8 ◽

2018 ◽

Vol 39 (12) ◽

pp. 2107-2113 ◽

Cited By ~ 2

Author(s):

Hossein Pakdaman ◽

Mehdi Abbasi ◽

Koroush Gharagozli ◽

Farzad Ashrafi ◽

Hosein Delavar Kasmaei ◽

...

Keyword(s):

Multiple Sclerosis ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Double Blind ◽

Blind Trial ◽

Relapsing Remitting ◽

The comparative efficacy and safety of anti-CD20 monoclonal antibodies for relapsing-remitting multiple sclerosis: A network meta-analysis

IBRO Neuroscience Reports ◽

10.1016/j.ibneur.2021.08.003 ◽

2021 ◽

Vol 11 ◽

pp. 103-111

Author(s):

Mohammad Z.I. Asha ◽

Yousef Al-Asaad ◽

Sundos F.H. Khalil

Keyword(s):

Multiple Sclerosis ◽

Monoclonal Antibodies ◽

Meta Analysis ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Relapsing Remitting ◽

Anti Cd20 ◽

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(09)79049-0 ◽

2009 ◽

Vol 2009 ◽

pp. 99-103

Author(s):

O. Kantarci

Keyword(s):

Multiple Sclerosis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Relapsing Remitting ◽

Efficacy and safety of 2 doses of ponesimod (10 and 20 mg o.d.): Interim analysis of a phase II extension trial in relapsing-remitting multiple sclerosis

10.26226/morressier.59a3edabd462b8028d8951c5 ◽

2017 ◽

Author(s):

Eva Havrdova

Keyword(s):

Multiple Sclerosis ◽

Phase Ii ◽

Interim Analysis ◽

Efficacy And Safety ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Extension Trial

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)

Case Medical Research ◽

10.31525/ct1-nct03846219 ◽

2000 ◽

Author(s):

Keyword(s):

Multiple Sclerosis ◽

Efficacy And Safety ◽

Relapsing Remitting ◽

Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience

Therapeutic Advances in Neurological Disorders ◽

10.1177/1756286418796404 ◽

2018 ◽

Vol 11 ◽

pp. 175628641879640 ◽

Cited By ~ 6

Author(s):

Emanuele D’Amico ◽

Aurora Zanghì ◽

Graziella Callari ◽

Giovanna Borriello ◽

Antonio Gallo ◽

...

Keyword(s):

Multiple Sclerosis ◽

Dimethyl Fumarate ◽

Comparable Efficacy ◽

Real Word ◽

Efficacy And Safety ◽

Relapsing Remitting ◽

Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis with a Suboptimal Response to Previous Disease-Modifying Therapies (1-Year Interim Results)

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2019.11.063 ◽

2020 ◽

Vol 37 ◽

pp. 101588

Author(s):

Patrick Vermersch ◽

Juha-Pekka Erälinna ◽

Richard Nicholas ◽

Celia Oreja-Guevara ◽

Aksel Siva ◽

...

Keyword(s):

Multiple Sclerosis ◽

Efficacy And Safety ◽

Disease Modifying Therapies ◽

Relapsing Remitting ◽

Disease Modifying ◽

Relapsing Remitting Multiple Sclerosis ◽

Previous Disease

Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis

CNS Drugs ◽

10.1007/s40263-019-00691-7 ◽

2020 ◽

Vol 34 (1) ◽

pp. 65-92 ◽

Cited By ~ 3

Author(s):

Damiano Paolicelli ◽

Alessia Manni ◽

Antonio Iaffaldano ◽

Maria Trojano

Keyword(s):

Multiple Sclerosis ◽

Efficacy And Safety ◽

Relapsing Remitting ◽